199 related articles for article (PubMed ID: 15780588)
1. Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes.
Baillie GS; Houslay MD
Curr Opin Cell Biol; 2005 Apr; 17(2):129-34. PubMed ID: 15780588
[TBL] [Abstract][Full Text] [Related]
2. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.
Baillie GS; Sood A; McPhee I; Gall I; Perry SJ; Lefkowitz RJ; Houslay MD
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):940-5. PubMed ID: 12552097
[TBL] [Abstract][Full Text] [Related]
3. The role of ERK2 docking and phosphorylation of PDE4 cAMP phosphodiesterase isoforms in mediating cross-talk between the cAMP and ERK signalling pathways.
Houslay MD; Baillie GS
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1186-90. PubMed ID: 14641023
[TBL] [Abstract][Full Text] [Related]
4. Beta-arrestin-recruited phosphodiesterase-4 desensitizes the AKAP79/PKA-mediated switching of beta2-adrenoceptor signalling to activation of ERK.
Houslay MD; Baillie GS
Biochem Soc Trans; 2005 Dec; 33(Pt 6):1333-6. PubMed ID: 16246112
[TBL] [Abstract][Full Text] [Related]
5. RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2 cells.
Lynch MJ; Baillie GS; Mohamed A; Li X; Maisonneuve C; Klussmann E; van Heeke G; Houslay MD
J Biol Chem; 2005 Sep; 280(39):33178-89. PubMed ID: 16030021
[TBL] [Abstract][Full Text] [Related]
6. An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics.
Willoughby D; Wong W; Schaack J; Scott JD; Cooper DM
EMBO J; 2006 May; 25(10):2051-61. PubMed ID: 16642035
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase-4 influences the PKA phosphorylation status and membrane translocation of G-protein receptor kinase 2 (GRK2) in HEK-293beta2 cells and cardiac myocytes.
Li X; Huston E; Lynch MJ; Houslay MD; Baillie GS
Biochem J; 2006 Mar; 394(Pt 2):427-35. PubMed ID: 16356165
[TBL] [Abstract][Full Text] [Related]
8. The molecular machinery for cAMP-dependent immunomodulation in T-cells.
Taskén K; Stokka AJ
Biochem Soc Trans; 2006 Aug; 34(Pt 4):476-9. PubMed ID: 16856837
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced remodelling of PDE4 isoform expression and cAMP handling in human pulmonary artery smooth muscle cells.
Millen J; MacLean MR; Houslay MD
Eur J Cell Biol; 2006 Jul; 85(7):679-91. PubMed ID: 16458997
[TBL] [Abstract][Full Text] [Related]
10. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.
Bolger GB; Baillie GS; Li X; Lynch MJ; Herzyk P; Mohamed A; Mitchell LH; McCahill A; Hundsrucker C; Klussmann E; Adams DR; Houslay MD
Biochem J; 2006 Aug; 398(1):23-36. PubMed ID: 16689683
[TBL] [Abstract][Full Text] [Related]
11. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.
Houslay MD; Adams DR
Biochem J; 2003 Feb; 370(Pt 1):1-18. PubMed ID: 12444918
[TBL] [Abstract][Full Text] [Related]
12. cAMP-specific phosphodiesterase-4D5 (PDE4D5) provides a paradigm for understanding the unique non-redundant roles that PDE4 isoforms play in shaping compartmentalized cAMP cell signalling.
Lynch MJ; Baillie GS; Houslay MD
Biochem Soc Trans; 2007 Nov; 35(Pt 5):938-41. PubMed ID: 17956250
[TBL] [Abstract][Full Text] [Related]
13. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling.
Houslay MD; Baillie GS; Maurice DH
Circ Res; 2007 Apr; 100(7):950-66. PubMed ID: 17431197
[TBL] [Abstract][Full Text] [Related]
14. Role of cAMP phosphodiesterase 4 in regulation of T-cell function.
Bjørgo E; Taskén K
Crit Rev Immunol; 2006; 26(5):443-51. PubMed ID: 17341187
[TBL] [Abstract][Full Text] [Related]
15. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins.
Perry SJ; Baillie GS; Kohout TA; McPhee I; Magiera MM; Ang KL; Miller WE; McLean AJ; Conti M; Houslay MD; Lefkowitz RJ
Science; 2002 Oct; 298(5594):834-6. PubMed ID: 12399592
[TBL] [Abstract][Full Text] [Related]
16. Negative feedback exerted by cAMP-dependent protein kinase and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes: an in vivo study using adenovirus-mediated expression of CNG channels.
Rochais F; Vandecasteele G; Lefebvre F; Lugnier C; Lum H; Mazet JL; Cooper DM; Fischmeister R
J Biol Chem; 2004 Dec; 279(50):52095-105. PubMed ID: 15466415
[TBL] [Abstract][Full Text] [Related]
17. Dynamic regulation, desensitization, and cross-talk in discrete subcellular microdomains during beta2-adrenoceptor and prostanoid receptor cAMP signaling.
Willoughby D; Baillie GS; Lynch MJ; Ciruela A; Houslay MD; Cooper DM
J Biol Chem; 2007 Nov; 282(47):34235-49. PubMed ID: 17855344
[TBL] [Abstract][Full Text] [Related]
18. PDE4: arrested at the border.
Brunton LL
Sci STKE; 2003 Oct; 2003(204):PE44. PubMed ID: 14560046
[TBL] [Abstract][Full Text] [Related]
19. Spatial organisation of AKAP18 and PDE4 isoforms in renal collecting duct principal cells.
McSorley T; Stefan E; Henn V; Wiesner B; Baillie GS; Houslay MD; Rosenthal W; Klussmann E
Eur J Cell Biol; 2006 Jul; 85(7):673-8. PubMed ID: 16500722
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterases and compartmentalized cAMP signalling in the heart.
Zaccolo M
Eur J Cell Biol; 2006 Jul; 85(7):693-7. PubMed ID: 16466668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
